These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 19893036)

  • 1. Syk tyrosine kinase acts as a pancreatic adenocarcinoma tumor suppressor by regulating cellular growth and invasion.
    Layton T; Stalens C; Gunderson F; Goodison S; Silletti S
    Am J Pathol; 2009 Dec; 175(6):2625-36. PubMed ID: 19893036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential roles of cyclin D1 and D3 in pancreatic ductal adenocarcinoma.
    Radulovich N; Pham NA; Strumpf D; Leung L; Xie W; Jurisica I; Tsao MS
    Mol Cancer; 2010 Feb; 9():24. PubMed ID: 20113529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulated expression of IL‑28RA is involved in the pathogenesis of pancreatic ductal adenocarcinoma.
    Liu L; Qi Y; Huang D; Xu Y; Li M; Hong Z; Gu Y; Jia B; Luo X; Zhang S; Zhang S
    Int J Oncol; 2021 Aug; 59(2):. PubMed ID: 34195850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of protein expression regulated by lumican in PANC‑1 cells using shotgun proteomics.
    Yamamoto T; Kudo M; Peng WX; Naito Z
    Oncol Rep; 2013 Oct; 30(4):1609-21. PubMed ID: 23846574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activated leukocyte cell adhesion molecule regulates the interaction between pancreatic cancer cells and stellate cells.
    Zhang WW; Zhan SH; Geng CX; Sun X; Erkan M; Kleeff J; Xie XJ
    Mol Med Rep; 2016 Oct; 14(4):3627-33. PubMed ID: 27573419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KiSS‑1‑mediated suppression of the invasive ability of human pancreatic carcinoma cells is not dependent on the level of KiSS‑1 receptor GPR54.
    Wang CH; Qiao C; Wang RC; Zhou WP
    Mol Med Rep; 2016 Jan; 13(1):123-9. PubMed ID: 26572251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small Nucleolar Noncoding RNA SNORA23, Up-Regulated in Human Pancreatic Ductal Adenocarcinoma, Regulates Expression of Spectrin Repeat-Containing Nuclear Envelope 2 to Promote Growth and Metastasis of Xenograft Tumors in Mice.
    Cui L; Nakano K; Obchoei S; Setoguchi K; Matsumoto M; Yamamoto T; Obika S; Shimada K; Hiraoka N
    Gastroenterology; 2017 Jul; 153(1):292-306.e2. PubMed ID: 28390868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PKC Delta (PKCdelta) promotes tumoral progression of human ductal pancreatic cancer.
    Mauro LV; Grossoni VC; Urtreger AJ; Yang C; Colombo LL; Morandi A; Pallotta MG; Kazanietz MG; Bal de Kier Joffé ED; Puricelli LL
    Pancreas; 2010 Jan; 39(1):e31-41. PubMed ID: 19924022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human amniotic fluid mesenchymal stem cells attenuate pancreatic cancer cell proliferation and tumor growth in an orthotopic xenograft mouse model.
    Chen YC; Lan YW; Huang SM; Yen CC; Chen W; Wu WJ; Staniczek T; Chong KY; Chen CM
    Stem Cell Res Ther; 2022 Jun; 13(1):235. PubMed ID: 35659367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of pancreatic tumor potential by overexpression of protein kinase C β1.
    Cirigliano SM; Mauro LV; Grossoni VC; Colombo LL; Diament MJ; Kazanietz MG; Bal de Kier Joffé ED; Puricelli LI; Urtreger AJ
    Pancreas; 2013 Oct; 42(7):1060-9. PubMed ID: 23695799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PRMT1 promotes pancreatic cancer growth and predicts poor prognosis.
    Song C; Chen T; He L; Ma N; Li JA; Rong YF; Fang Y; Liu M; Xie D; Lou W
    Cell Oncol (Dordr); 2020 Feb; 43(1):51-62. PubMed ID: 31520395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of bone sialoprotein on pancreatic cancer cell growth, invasion and metastasis.
    Kayed H; Kleeff J; Keleg S; Felix K; Giese T; Berger MR; Büchler MW; Friess H
    Cancer Lett; 2007 Jan; 245(1-2):171-83. PubMed ID: 16488077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dying tumor cells stimulate proliferation of living tumor cells via caspase-dependent protein kinase Cδ activation in pancreatic ductal adenocarcinoma.
    Cheng J; Tian L; Ma J; Gong Y; Zhang Z; Chen Z; Xu B; Xiong H; Li C; Huang Q
    Mol Oncol; 2015 Jan; 9(1):105-14. PubMed ID: 25156550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of aberrant maspin expression on the invasive ability of pancreatic ductal adenocarcinoma cells.
    Hong SN; Lee JK; Choe WH; Ha HY; Park K; Sung IK; Lee KT; Kim JJ; Rhee JC
    Oncol Rep; 2009 Feb; 21(2):425-30. PubMed ID: 19148518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic regulation and role of metastasis suppressor genes in pancreatic ductal adenocarcinoma.
    Mardin WA; Haier J; Mees ST
    BMC Cancer; 2013 May; 13():264. PubMed ID: 23718921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CBX7 suppresses cell proliferation, migration, and invasion through the inhibition of PTEN/Akt signaling in pancreatic cancer.
    Ni S; Wang H; Zhu X; Wan C; Xu J; Lu C; Xiao L; He J; Jiang C; Wang W; He Z
    Oncotarget; 2017 Jan; 8(5):8010-8021. PubMed ID: 28030829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant expression of a disintegrin and metalloproteinase 17/tumor necrosis factor-alpha converting enzyme increases the malignant potential in human pancreatic ductal adenocarcinoma.
    Ringel J; Jesnowski R; Moniaux N; Lüttges J; Ringel J; Choudhury A; Batra SK; Klöppel G; Löhr M
    Cancer Res; 2006 Sep; 66(18):9045-53. PubMed ID: 16982746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early epigenetic downregulation of WNK2 kinase during pancreatic ductal adenocarcinoma development.
    Dutruel C; Bergmann F; Rooman I; Zucknick M; Weichenhan D; Geiselhart L; Kaffenberger T; Rachakonda PS; Bauer A; Giese N; Hong C; Xie H; Costello JF; Hoheisel J; Kumar R; Rehli M; Schirmacher P; Werner J; Plass C; Popanda O; Schmezer P
    Oncogene; 2014 Jun; 33(26):3401-10. PubMed ID: 23912455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circular RNA ciRS-7 promotes the proliferation and metastasis of pancreatic cancer by regulating miR-7-mediated EGFR/STAT3 signaling pathway.
    Liu L; Liu FB; Huang M; Xie K; Xie QS; Liu CH; Shen MJ; Huang Q
    Hepatobiliary Pancreat Dis Int; 2019 Dec; 18(6):580-586. PubMed ID: 30898507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of Disabled-2 Expression in Pancreatic Cancer Progression.
    Hocevar BA
    Sci Rep; 2019 May; 9(1):7532. PubMed ID: 31101868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.